Deksametazon Pliva 4 mg tablete

Name	Deksametazon Pliva 4 mg tablete
Marketing Authorisation Number	HR-H-585079018
Active Substance	deksametazon
Composition	svaka tableta sadrži 4 mg deksametazona
Pharmaceutical Form	Tableta
Manufacturer	Merckle GmbH, Blaubeuren, Baden-Wuerttemberg, Njemačka
Marketing Authorisation Holder	Pliva Hrvatska d.o.o., Prilaz baruna Filipovića 25, Zagreb, Hrvatska
Marketing Authorisation Date	13.12.2021
MA Period of Validity	13.12.2026
Classification Number	UP/I-530-09/21-01/61
Registration Number	381-12-01/154-21-04
Prescription	Medicinal product subject to medical prescription
Type of prescription	Medicinal product subject to restricted medical prescription
Distribution	Supply through pharmacies (community)
Advertising to general public	not allowed
ATC Code	H02AB02
Marketing status	Marketed
Shortage status	No shortage
SmPC	download
PL	download
Public Assessment Report	download

Packaging description	MA Number for Packaging	Marketing status	Shortage status
20 tableta u blisteru, u kutiji	HR-H-585079018-01	Marketed	No shortage
50 tableta u blisteru, u kutiji	HR-H-585079018-02	Never marketed	-
100 tableta u blisteru, u kutiji	HR-H-585079018-03	Never marketed	-
20 tableta u blisteru, u kutiji (bolničko pakiranje)	HR-H-585079018-04	Never marketed	-
50 tableta u blisteru, u kutiji (bolničko pakiranje)	HR-H-585079018-05	Never marketed	-
100 tableta u blisteru, u kutiji (bolničko pakiranje)	HR-H-585079018-06	Never marketed	-
10 tableta u blisteru, u kutiji	HR-H-585079018-07	Never marketed	-

Medicinal Products